About Beijing Beilu Pharmaceutical Company

The company was founded in September 1992. The company is mainly engaged in R&D, production and sales of pharmaceutical products, and is a national high-tech enterprise and the first batch of enterprises listed on the GEM. The company's main business is still research on contrast agents, APIs, central nervous system drugs, and hypoglycemic drugs Distribution, production and sales. Main products: Gadobutyl Glucamine Injection, Gadobutrol Injection, Gadobutyl Glucamide Injection, Iodohexanol Injection, Iodopazole Injection, Glimepiride Tablets, Reglenide Tablets, Plaxol Hydrochloride Sustained-Release Tablets, Jiuwei Zhenxin Granules, Gadobentil and Excipients, Iodotrexanol, Iodopromide and Iodopanol, etc. The company received honors such as the National High-tech Enterprise Certification Certificate, 100 Innovative Pilot Enterprises in Zhongguancun Science and Technology Park, Zhongguancun High-tech Enterprises, A-level Tax Credit Enterprises, and the National Torch Program. It has received honorary titles such as Zhejiang Water-Saving Enterprise, Taizhou Green Factory, and Taizhou “Waste-free Factory”. It won the “Top 500 High-tech Enterprises in China” for 2 consecutive years, the “Beijing Top 100 Private Enterprises in Social Responsibility” for the 3rd year in a row, and also won the honorary title of “Top 500 Chinese Enterprises for Rural Revitalization”.